Active tuberculosis (Not FDA approved)
Active tuberculosis (Not FDA approved)
Renal Dose Adjustment (Based on CrCl)
Hepatic Dose Adjustment
Cautions: Use cautiously in
Mycobutin interacts with :
Pregnancy Category:B
Breastfeeding: Safety unknown. According to the American Academy of Pediatrics, nursing women who have been treated 
2 weeks and who are not considered contagious may breastfeed. This information is based upon LactMed database (available at http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT last accessed 26 July 2010) Manufacturer recommends discontinuation of breastfeeding, or postponing of treatment (taking into account the importance of the drug to the mother).
US Trade Name(s)
US Availability
rifabutin (generic)
Mycobutin
Canadian Trade Name(s)
Canadian Availability
Mycobutin
UK Trade Name(s)
UK Availability
Mycobutin
Australian Trade Name(s)
Australian Availability
Mycobutin
Antimicrobials
Antituberculosis AgentsRifamycin Derivatives
Infectious Disease
Antituberculosis AgentsRifamycin Derivatives
Pricing data from www.DrugStore.com in U.S.A.
Warning: This pricing information is subject to change at the sole discretion of DS Pharmacy. For the most current and up-to-date pricing information, please visit drugstore.com.
Drug Name: Mycobutin 150 MG Oral Capsule
Pill Image:
Ingredient(s): Rifabutin
Imprint: MYCOBUTIN;PHARMACIA;UPJOHN
Color(s): Red
Shape: Capsule
Size (mm): 21.00
Score: 1
Inactive Ingredient(s): cellulose, microcrystalline / magnesium stearate / ferric oxide red / silicon dioxide / sodium lauryl sulfate / titanium dioxide
Drug Label Author:
Pharmacia and Upjohn Company
DEA Schedule:
Non-Scheduled
[